Experimental and Theoretical Insights of Functionalized Hexavanadates on Na+/K+-ATPase Activity; Molecular Interaction Field, Ab Initio Calculations and in Vitro Assays.

Nada Bosnjakovic-Pavlovic,Xiao Xu,Danijela Krstic,Jean-Michel Gilleta,Yongge Wei,Pingfan Wu,Mirjana Colovic,Anne Spasojevic-de Bire
DOI: https://doi.org/10.1016/j.jinorgbio.2019.110720
IF: 4.336
2019-01-01
Journal of Inorganic Biochemistry
Abstract:The influence of three functionalized hexavanadates (V-6): Na-2 [V6O13{(OCH2)(3)CCH3}(2)], [H-2](2) [V6O13{(OCH2)(3)CCH2OCOCH2CH3}(2)] and [(C4H9)(4)N](2) [V6O13{(OCH2)(3)CCH2OOC(CH3)(2)-COOH}(2) on Na+/K+-ATPase activity, was investigated in vitro. Including compounds already tested by Xu et al. (Journal of Inorganic Biochemistry 161 (2016) 27-36), all functionalized hexavanadates inhibit the activity of Na+/K+-ATPase in a dose-dependent manner but with different inhibitory potencies. Na-2 [V6O13{(OCH2)(3)CCH3}(2)] was found to have the best inhibition properties - showing 50% inhibition IC50 = 5.50 x 10(-4) M, while [(C4H9)(4)N](2) [V6O13{(OCH2)(3)CCH2OOC(CH3)(2)-COOH}(2)] showed the lowest inhibitory power, IC50 = 1.31 x 10(-4)M. In order to understand the bioactivity of functionalized hexavanadates series, we have also used a combined theoretical approach: determination of electrostatic potential from ab initio theoretical calculations and computation of the molecular interaction field (MIF) surface.
What problem does this paper attempt to address?